| Literature DB >> 27453588 |
José L Vera1, Jorge Rullán1, Natasha Santos1, Jesús Jiménez1, Joshua Rivera1, Alberto Santana1, Jon Briggs2, Arnold L Rheingold2, Jaime Matta3, Enrique Meléndez1.
Abstract
Six ferrocenecarboxylates with phenyl, 4-(1H-pyrrol-1-yl)phenyl, 4-fluorophenyl, 4-chlorophenyl, 4-bromophenyl, 4-iodophenyl as pendant groups were synthesized and fully characterized by spectroscopic, electrochemical and X-ray diffraction methods. The anti-proliferative activity of these complexes were investigated in hormone dependent MCF-7 breast cancer and MCF-10A normal breast cell lines, to determine the role of the para substituent on the phenoxy pendant group. The 4-fluorophenyl ferrocenecarboxylate is inactive in both cell lines while 4-(1H-pyrrol-1-yl)phenyl ferrocenecarboxylate is highly cytotoxic in both cell lines. 4-chlorophenyl and 4-bromophenyl ferrocenecarboxylates have moderate to good anti-proliferative activity in MCF-7 and low anti-proliferative activity on normal breast cell line, MCF-10A whereas the 4-iodophenyl analog is highly toxic on normal breast cell line. The phenyl ferrocenecarboxylate has proliferative effects on MCF-7 and is inactive in MCF-10A. Docking studies between the complexes and the alpha-estrogen receptor (ERα) were performed to search for key interactions which may explain the anti-proliferative activity of 4-bromophenyl ferrocenecarboxylate. Docking studies suggest the anti-proliferative activity of these ferrocenecarboxylates is attributed to the cytotoxic effects of the ferrocene group and not to anti-estrogenic effects.Entities:
Keywords: Anti-cancer; Docking; Estrogen receptor; Ferrocenecarboxylate; MCF-10A; MCF-7
Year: 2014 PMID: 27453588 PMCID: PMC4957819 DOI: 10.1016/j.jorganchem.2013.10.002
Source DB: PubMed Journal: J Organomet Chem ISSN: 0022-328X Impact factor: 2.369